High-Purity Pyrido[2,3-d]Pyrimidine Intermediate for Advanced Oncology Research

Published Jan 22, 2026 by Pharmaffiliates
Analytical Method Development for Pharmaceutical Formulations

2-(8-Cyclopentyl-5-methyl-7-oxo-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)acetaldehyde (CAS 2204368-66-9)


Product Overview

2-(8-Cyclopentyl-5-methyl-7-oxo-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)acetaldehyde is a structurally complex heterocyclic aldehyde derivative widely recognized as a critical intermediate and impurity reference standard in the synthesis of CDK4/6 inhibitor–based oncology APIs.
Belonging to the pyrido[2,3-d]pyrimidine chemical class, this compound plays an important role in drug development, impurity profiling, and analytical method validation, particularly for kinase-targeted anticancer molecules.

Why This Compound Is Important in Pharmaceutical R & D

The presence of an acetaldehyde functional group combined with a piperazinyl-substituted pyridine moiety makes this compound chemically reactive and analytically significant. Such structures often emerge during multi-step synthesis and must be identified, characterized, and controlled to meet global regulatory expectations.
This compound is commonly used for:

  • Impurity identification and qualification
  • Analytical method development (HPLC, LC-MS, NMR)
  • Stability and degradation pathway studies
  • Reference standard applications in regulated laboratories

Regulatory & Quality Relevance

In line with ICH Q3A/Q3B guidelines, pharmaceutical manufacturers are required to monitor and control process-related and degradation impurities. 2-(8-Cyclopentyl-5-methyl-7-oxo-…acetaldehyde) serves as a well-characterized impurity standard, supporting:

  • Accurate impurity quantification
  • Robust API release testing
  • Regulatory submissions and compliance

Its availability as a characterized reference material significantly reduces analytical uncertainty during drug development and lifecycle management.

Applications

  • Oncology API development programs
  • CDK inhibitor impurity profiling
  • CRO and CDMO analytical laboratories
  • Pharmaceutical R&D and regulatory studies
  • Method validation and forced degradation studies

Why Choose Pharmaffiliates

Pharmaffiliates supplies high-purity pharmaceutical intermediates and impurity standards manufactured under stringent quality systems. Each material is supported with:

  • Comprehensive Certificate of Analysis (CoA)
  • Advanced spectral characterization
  • Reliable batch-to-batch consistency
  • Custom synthesis and scale-up support on request
Palbociclib-impurities

Conclusion

2-(8-Cyclopentyl-5-methyl-7-oxo-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)acetaldehyde is an essential compound for high-precision pharmaceutical research, enabling accurate impurity control and regulatory-ready analytics for oncology drug development.

Leave a Reply